Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-12
2000-10-31
Mach, D. M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514280, 514285, 544233, 546 41, 546 48, 546 61, 546 70, C07D23726, C07D47100, C07D22118
Patent
active
061403288
ABSTRACT:
The invention provides compounds of formula I: wherein
REFERENCES:
patent: Re26065 (1966-07-01), Marvel et al.
patent: 2985661 (1961-05-01), Hien et al.
patent: 3449330 (1969-06-01), Guglielmetti et al.
patent: 3538097 (1970-11-01), Lowe et al.
patent: 3912740 (1975-10-01), Zee-Chang et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 5106863 (1992-04-01), Hajos et al.
patent: 5112532 (1992-05-01), Ninomiya et al.
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5244903 (1993-09-01), Wall et al.
patent: 5318976 (1994-06-01), Luzzi et al.
Aquirre, J.M., et al., "Reaction of 1,2-diarylethylamides with ethyl polyphosphate (EPP): correlation of the von Braun, Ritter and Bischler-Napieralski reactions", Chemical Abstracts, vol. 111, No. 13,, Abstract No. 115004, J. Heterocycl.Chem; 89 vol. 26(1), pp. 25-27, (Sep. 25, 1989).
Badia, D., et al., "Silicon-mediated isoquinoline synthesis: preparation and stereochemical characterization of 4-hydroxy-3-phenylisoquinolines", Chemical Abstracts, vol. 117, No. 13, Abstract No. 131034, Tetrahedron; 92, vol. 48 (21), pp. 4419-4430, (Sep. 28, 1992).
Baezner, C., et al., "Uberfuhrung von o-nitro- und o,p-dinitro-benzylchlorid in acridinderivate", Berichte der Deutschen Chemischn Gessellschaft, vol. 39, pp. 2438-2447, (1906).
Bathini, Y., et al., "Convenient Routes to Substituted Benzimidazoles and Imidazolo[4,5-b]pyridines Using Nitrobenzene as Oxidant", Synthetic Communications, 20(7), 955-963, (1990).
Bradsher, C.K., et al., ".alpha-Acyl-o-tolunitriles as intermediates in the preparation of 3-substituted isoquinolines and 1-amino-2-benzopyrylium derivatives", Chemical Abstracts, vol. 089, No. 21, Abstract No. 179810, 3817-3820, (1978).
Buu-Hoi, N., "The chemistry of carcinogenic nitrogen compounds. Part V. Angular hydroxybenzacridines and hydroxydibenzacridines", Journal of the Chemical Society, Letchworth GB, pp. 2096-2099, (1950).
Buu-Hoi, N., et al., "The chemistry of carcinogenic nitrogen compounds. Part X. The pfitzinger reaction in the synthesis of 1:2 benzacridines", Journal of the Chemical Society, Letchworth, GB, pp. 279-281, (1952).
Chen, A.Y., et al., "A New Mammalian DNA Topoisomerase I Poison Hoechst 33342: Cytoxicity and Drug Resistance in Human Cell Cultures", Cancer Research, vol. 53, pp. 1332-1337, (Mar. 15, 1993).
Chen, A.Y., et al., "DNA Minor Groove-Binding Ligands: A Different Class of Mammalian DNA Topoisomerase I Inhibitors", Proc. Natl. Acad. Sci., USA,, vol. 90, pp. 8131-8135, (Sep. 1993).
Chen, A.Y., et al., "DNA Topoisomerases: Essential Enzymes and Lethal Targets", Annu. Rev. Pharmacol. Toxicol.,, vol. 34, pp. 191-218, (1994).
Cherif, A., et al., "N-(5,5-Diacetoxypent-l-yl)doxorubicin: A New Intensely Potent Doxorubicin Analogue", J. Med. Chem., 35, 3208-3214, (1992).
Croisy, M., et al., "Synthesis and Carcinogenic Activity of Oxidized Benzacridines: Potential Metabolites of the strong carcinogen 7-Methylbenz[c]acridine and of the inactive isomer 12-methylbenz[a]acridine", J. Med. Chem, 26, pp. 303-306, (1983).
D'arpa, P., et al., "Topoisomerase-Targeting Antitumor Drugs", Biochimica et Biophysica Acta, 989, 163-177 (1989).
Dominguez, E., et al., "Dehydrogenation reactions of 1-substituted-3-aryltetrahydroisoquin oline derivatives", Chemical Abstracts, vol. 101, No. 11, Abstract No. 090742, 525-528, (1984).
Dorofeenko, G.N., et al., "Synthesis of 3-aryl derivatives of 2-benzopyrylium salts with free.alpha-positions", Chemical Abstracts, vol. 074, No. 15, Abstract No. 076295, 1013-1014, (1971).
Fitzgerald, J.J., et al., "Reaction of benzocyclobutene oxides with nitriles: synthesis of hypecumine and other 3-substituted isoquinolines", Chemical Abstracts, vol. 122, No. 7, Abstract No. 081704, Tetrahedron Lett.; 94; vol. 35, (49), pp. 9191-9194, (Feb. 13, 1995).
Fox, G.J., et al., "para-Bromination of Aromatic Amines: 4-Bromo-N,N-Dimethyl-3-(Trifluoromethyl)Aniline", Org. Syn., 55, 20-23, (1973).
Fujii, N., et al., "Induction of Mammalian DNA Topoisomerase I-mediated DNA Cleavage and DNA Winding by Bulgarein", Journal of Biological Chemistry, vol. 268, pp. 13160-13165, (1993).
Gallo, R.C., et al., "Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin", Journal of the National Cancer Institute, 46, 789-795 (Apr. 1971).
Gandhi, K.K., et al., "Regioselective thermal cyclization of 3-substituted arylenaminoimine hydrochlorides, a convenient method for the synthesis of functionalized polycyclic quinoline derivatives", Heterocycles, vol. 41, No. 5, Amsterdam, NL, pp. 911-920, (1995).
Garcia, A., et al., "A simple direct approach to 1-substituted 3-arylisoquinolines from deoxybenzoins and nitriles", Chemical Abstracts, vol. 110, No. 25, Abstract No. 231407, Tetrahedron; 88; vol. 44(21);, pp. 6681-6686, (Jun. 19, 1989).
Gatto, B., et al., "Identification of Topoisomerase I as the Cyctotoxic Target of the Protoberberine Alkaloid Coralyne", Cancer Res., 56, 2795-2800, (1996).
Giovanella, B.C., et al., "Complete Growth Inhibition of Human Cancer Xenografts in Nude Mice by Treatment with 20-(S)--Camptothecin", Cancer Research, 51, 3052-3055 (Jun. 1, 1991).
Hoan, N., et al., "Syntheses from o-halogenated anisoles and phenetoles", Chemical Abstracts, Abstr. No. 6571bg, vol. 41, No. 20, Columbus, Ohio, (Oct. 20, 1947).
Iwao, M., et al., "A Regiospecific Synthesis of Carbazones via Consecutive Palladium-Catalyzed Cross-coupling and Aryne-Mediated Cyclization", Heterocycles, 36, 1483-1488, (1993).
Janin, Y.L., et al., "Synthesis and Evaluation of New 6-Amino-Substituted Benzo[c]phenanthridine Derivatives", J. Med. Chem, vol. 36, No. 23, pp. 3686-3692, (1993).
Kametani, T., et al., "Studies on the synthesis of heterocyclic compounds. DCXXVII. The formation of 2,3,9,10-tetramethoxybenz[c]acridine by treatment of 6,7-dimethoxy-1-(4,5-dimethoxy-2-nitrophen ethyl)-2methylisoquinoline with triethyl phosphite", Chemical and Pharmaceutical Bulletin, vol. 23, No. 9, pp. 2025-2028, (1975).
Kim, J.S., et al., "Influence of steric factors on topoisomerase I inhibition and cytotoxicity of bisbenzimidazoles related to Hoechst 33342", Abstract 4, 86th annual meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, 2689, (1995).
Kim, J.S., et al., "Steric factors associated with the topoisomerase I inhibition and cytotoxicity of substituted bisbenzimidazoles", Abstract 10, American Assn of Pharmaceutical Scientists, Eastern Regional Meeting, 27, (1995).
Kim, J.S., et al., "Structure-activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerase I Poisons", Bioorganic & Med. Chem., 4, 621-630, (1996).
Kim, J.S., et al., "Substituted 2,5'-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity", J. Med. Chem., vol. 39, 992-998, (1996).
Kitamura, T., et al., "Isoquinoline derivatives from the Ritter-type reaction of vinyl cations", Chemical Abstracts, vol. 102, No. 1, Abstract No. 006157, Chem. Lett.; 84;(8);, pp. 1351-1354, (Jan. 7, 1985).
LaVoie, E.J., et al., "Structure-activity studies related to minor groove-binding ligands which inhibit mammalian DNA topoisomerase I", Abstract 1, 85th Annual Meeting of American Association for Cancer Research, Apr. 10-13, 1994, San Francisco, CA, 2699, (1994).
Makhey, D., et al., "Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons", Bioorg. & Med. Chem. Lett., vol. 4, 781-791, (1996).
Makhey, D., et al., "Protoberberine Alkaloids and Related Compounds as Dual Inhibitors of Mammalian Topoisomerase I and II", Med Chem. Res., vol. 5, 1-12, (1994).
Meegalla, S.K., et al., "Synthesis and Pharmacological Evaluation of Isoindolo[1,2-b]quinazolinone and Isoindolo[2,1-a]benzimidazole Derivatives Related to the Antitumor Agent Batracylin", J. Med. Chem., 37, 3434-3439, (1994).
Memetzidis, G., et al., "Structure-affinity relationships of berbines or 5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizines at.alpha.-adrenoceptors", Chemical Abstracts, vol. 117, No. 3, Abstract No. 019892, Eur. J. Med. Chem.; 91; vol. 26 (6), pp. 605-611, (Jul. 20, 1992).
Mohanty, M., et al., "New Therapeutic
LaVoie Edmond J.
Liu Leroy Fong
Makhey Darshan B.
Zhao Bao-ping
Mach D. M.
Rutgers The State University of New Jersey
LandOfFree
Heterocyclic cytotoxic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic cytotoxic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic cytotoxic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052044